Normal basal laminas are realized on dystrophic Schwann cells in dystrophic in equilibrium shiverer chimera nerves by unknown
Normal 
Cells  in 
Basal  Laminas 
Dystrophic.  - - 
Are  Realized  on  Dystrophic 
Shiverer Chimera  Nerves 
Schwann 
ALAN  C.  PETERSON and  GARTH M.  BRAY 
Department of Neurology and Neurosurgery, McGill University, The Neuroscience Unit, Montreal General 
Hospital Research Institute, Montreal, Quebec Canada H3G 1A4 
ABSTRACT  Multiple  discontinuities  are  observed in  the  basal laminas of Schwann cells in 
mature dystrophic  mice. To explore the pathogenesis of this abnormality we have exploited 
a dystrophic ~-~ shiverer mouse chimera preparation in which both the basal lamina phenotype 
and the genotype of myelin-forming  Schwann cells can be determined.  If the basal lamina 
abnormality  were to arise from an intrinsic deficiency  of the dystrophic  Schwann cell itself, 
only  those  Schwann cells of  dystrophic  genotype  could  express the  mutant  phenotype, 
whereas the coexisting population  of shiverer Schwann cells should express'typically normal 
basal laminas. No such distinction was observed; rather both dystrophic and shiverer Schwann 
cells were found to express relatively normal basal laminas and two pathogenetic mechanisms 
remain theoretical  possibilities. The dystrophic  Schwann cell population  may be intrinsically 
defective but also may be rescued by obtaining the normal product of the dy locus synthesized 
by the coexisting shiverer cells. Alternatively, an extra Schwann cell deficiency existing within 
dystrophic mice may be normalized by shiverer cells and the normal intrinsic potential of both 
dystrophic and shiverer Schwann cells can then be realized. Regardless  of the exact mechanism 
underlying these findings, some extracellularly  mediated  influence,  emanating in vivo  from 
shiverer cells, is capable of ameliorating the basal lamina deficiency  typically  expressed by 
dystrophic Schwann cells. 
In the peripheral nervous system of mature dystrophic mice, 
two striking morphological abnormalities can be recognized. 
In certain spinal roots and cranial nerves, Schwann cells fail 
to  separate  and  ensheath  axons  so  that  groups  of closely 
apposed naked axons, normally seen only during early devel- 
opment,  persist (1,  2).  In the  remainder of the  dystrophic 
peripheral nervous system, relatively normal axon-Schwann 
cell  relationships  are  achieved  (3),  but  the  basal  laminas 
covering both myelinated and unmyelinated fibers have mul- 
tiple small gaps (4). 
Both of these morphological abnormalities are phenotypic 
deficiencies specific to Schwann cells; the presence of naked 
axons results from a  failure of the Schwann cell population 
to separate and ensheath the axons during primary develop- 
ment, and abnormal basal lamina has been observed only on 
the surface of Schwann cells. Various experimental manipu- 
lations of the peripheral nervous system in dystrophic mice 
have indicated that both of these "Schwann cell" deficiencies 
can  be  modified  during  regeneration  (5,  6)  and  in  tissue 
cultures (7, 8). Nevertheless, it is not yet known what cell type 
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or types are primarily responsible for the pathology observed 
in vivo. Although the in vitro experiments have indicated that 
endoneurial fibroblasts exert an important influence on the 
development of basal laminas by dystrophic Schwann cells, 
either the Schwann cell itself,  a defect expressed exclusively 
by some extra Schwann cell type, or a more complex inter- 
action  between  both  Schwann  cells  and  some  extra  glial 
element  sharing  the  same  intrinsic  deficiency  may be  in- 
volved. 
In an attempt to dissect this pathogenetic sequence, we have 
examined the basal lamina expressed within the peripheral 
nerves  of chimeras.  If the  basal  lamina  abnormalities  on 
Schwann cells in dystrophic mice were entirely a consequence 
of an intrinsic defect expressed by the Schwann cell itself, we 
would predict that within  these  chimera nerves only those 
Schwann cells of dystrophic genotype could express patchy 
basal laminas. However, if some component extrinsic to the 
Schwann cell itself were involved in the pathogenesis of this 
basal lamina abnormality, no such direct correlation would 
be expected. 
1831 In  dystrophic  mice,  Schwann  cells  of myelinated  nerve 
fibers express P1  myelin basic protein (MBP) 1 (9),  whereas, 
in shiverer mice, the MBP structural gene is abnormal (10), 
and shiverer Schwann cells, although otherwise affected only 
with subtle ultrastructural abnormalities (1 I, 12), contain no 
detectable P 1 MBP (13).  MBP is detectable with immunocy- 
tochemical techniques,  and therefore the genotype of every 
myelinated Schwann cell within dystrophic ~  shiverer chi- 
mera nerves can be established. Moreover, this procedure can 
be performed on sections of nerves embedded in plastic, and 
adjacent ultrathin sections permit an ultrastructural evalua- 
tion  of the basal lamina phenotype expressed on both the 
dystrophic (P1  positive) and shiverer (Pl  negative) Schwann 
cells coexisting within  the  same chimera  nerve.  Thus,  the 
object  of the  experiment  reported  here  was  to  determine 
whether or not the abnormalities expressed by Schwann cells 
in  dystrophic  mice would  be  reproduced  in  dystrophic 
shiverer chimeras, and if the mutant or normal phenotype of 
each Schwann cell would correlate directly with its genotype. 
MATERIALS  AND  METHODS 
Mice:  The dystrophic  coldhy  was maintained  by dy2J/dy z~ x  dyZ~/+ 
matings or by dy2J/dy 2" x  dy2J/dy 2" matings. The dy  2J allele is maintained  on 
the C57BL/6J background. 
The shiverer colony was founded by shi/+ mice generously provided by Dr. 
T.  Bird, Veteran's  Administration  Hospital,  Seattle, WA.  These  mice  were 
derived from multiple crosses between SWV, the strain in which the shiverer 
mutation occurred, and ICR. Since 1979, this stock has been maintained  as a 
closed colony in the animal facility of the Montreal General Hospital Research 
Institute. The colony of shiverer mice was maintained  by heterozygote (shi/+) 
matings and by shi/+ x  shi/shi matings (usually successful if the male was ~3 
mo old). 
dy2J/dy 2J ~  shi/shi  chimeras  were  produced  by  techniques  previously 
described (14). Embryos  derived from dy2J/dy 2J x dy2J/dy 2~ and shi/shi x  shi/ 
+ matings were aggregated at the eight-cell stage, cultured for 1 d, and surgically 
transplanted  to the  uterus of pseudopregnant  females to complete  in utero 
development. Seven chimeras were produced; coat color mosaicism and strain- 
specific isozymes of glucosephosphate isomerase demonstrated  the presence of 
both cell lines in each of these mice. However, as the embryos obtained  from 
the shiverer stock were derived from shi/shi x  shi/+ matings, only one-half of 
these chimeras were expected to contain  shi/shi cells, whereas the remainder 
should contain shi/+ cells. To establish the actual genotype of  the chimeras we 
relied upon the immunocytochemical  demonstration  of  two clearly demarcated 
classes of myelinated Schwann cells (MBP positive and MBP negative) within 
their peripheral nerves. Of the six chimeras analyzed, three were determined to 
be dyeJ/dy 2J ~  shi/shi.  These mice, identified as chimeras A, B, and C, were 
killed at  12 mo (chimeras A and B) and at 4 mo (chimera C). The presence of 
some myelin sheaths with an interdemiate  density of reaction product, and the 
failure to detect  any Pl-negative  ceils in the nerves  of the three  others was 
taken as evidence that their genotype was dy2J/d~2J ~  shi/+. 
Only  one of the seven chimeras  produced  for this study  expressed gross 
behavioral abnormalities  similar to a shiverer homozygote. It died at 9 mo of 
age and was not analyzed.  Of the remaining  chimeras,  only  1 (chimera  A) 
revealed any indication  of a  manifesting  disease by a  slightly asymmetrical 
flexion assumed by the hind limbs when it was suspended by the tail. 
Sample Preparations:  The chimeras were anesthetized with sodium 
pentobarbital  (M.T.C.  Pharmaceuticals,  Hamilton,  Canada)  and systemically 
perfused  with  1.5% glutaraldehyde  and  I%  paraformaldehyde  in a  0.2  M 
phosphate  buffer  at pH 7.4. Spinal  roots  and sciatic nerves were recovered 
within  l  h  and immersed  in cold  (4"C) 2%  osmium tetroxide  in a  0.1  M 
phosphate buffer (pH 7.6) for an additional  18-24 h. Each nerve was cut into 
segments 5-10  mm long and embedded  in epoxy resin (Epon)  by standard 
procedures. All materials were supplied by J. B. Electron Microscopy Services 
Inc., Dorval, Canada. 
Light  Microscopy:  0.5-t~m-thick cross sections  were cut with  glass 
knives on a Reichert ultramicrotome  (C. Reicbert, Wien, Austria) and stained 
with toluidine blue (Fisher Scientific Co. Ltd., St. Foy, Canada). Sections from 
at  least  one  block  from each  nerve  were  examined  by  light  microscopy, 
particularly for the presence of ensheathment defects. 
Abbreviation  used in this paper: MBP, myelin basic protein. 
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Immunocytochemistry:  The  primary antiserum used  throughout 
this study was raised in rabbits against the  18,500-mol-wt species of bovine 
central  nervous system  MBP  and  cross-reacts with  all  four bovine  central 
nervous system MBP species as well as the 18,500-mol-wt P1  MBP of rodent 
peripheral  nervous system. The antisera  was generously provided  by Dr.  P. 
Braun, Department of Biochemistry, McGiil University. A full description  of 
the immunocytochemical  techniques  used including the results of all control 
experiments  has been presented  elsewhere (15). In brief, 2-~m-thick sections 
were cut and mounted on 22-ram  square cover slips and dried at 6fl°C for a 
minimum of 4 h. To prepare the sections for immunocytochemistry,  the Epon 
was removed by immersing  the coverslips in sodium ethoxide, diluted  1:3 with 
absolute ethanol, for 10-30 rain. The coverslips were then washed in absolute 
ethanol  (four times for 2 rain),  immersed  in 0.1% H202 for 5 rain at room 
temperature,  and washed (three times for 10 min) with 0.5 M Tris HCL, pH 
7.6. The coverslips were then drained, and each section was covered first with 
100 gl of 3% normal goat serum (Sternberger-Meyer, Gaithersberg, MD) in 0.5 
M Tris HCL, pH 7.6, and incubated for 30 min at room temperature  followed 
by 50 ~1 of  P1 antiserum (l:1000) dilution, 0.5 M Tris HCL, pH 7.6, containing 
1%  NGS)  and  incubated  in  a  humidified  chamber at 4°C  overnight  (16). 
Peroxidasc-antiperoxidase immunocytochemieal  detection of bound rabbit an- 
tibody was then performed by standard  procedures (17) and the sections were 
subsequently  viewed with a  Leitz Orthoplan microscope  (E.  Leitz [Canada] 
Ltd., Midland, Canada). 
Electron Microscopy:  Uultrathin sections from the blocks containing 
chimera  nerves were mounted on copper grids, stained with lead citrate and 
uranyl acetate, and viewed with a Siemens 201 electron microscope (Siemens, 
Berlin,  Federal  Republic  of Germany).  Typically,  each  block  was serially 
sectioned in the following sequence: one 0.5-~m section for light microscopy, 
two 2-#m sections for immunocytochemieal  detection of Pl-positive  Schwann 
cells, and 5-10 ultrathin  sections for ultrastructural  analysis. A demonstration 
of the experimental approach is presented in Fig. 1. 
Basal  Lamina  Analysis:  The basal  laminas  of Pl-positive  and Pl- 
negative Sehwann cells were analyzed by identifying the same myelinated fibers 
in both semithin cross sections of nerve processed for PI immunocytocbemistry 
and in adjacent ultrathin sections examined by electron microscopy. Each fiber 
showing adequate  ultrastructural  myelin preservation was assigned a number 
that was recorded  directly  on a  light  micrograph  of the  same fiber  in the 
adjacent immunocytochemieal  preparation. 
The electron micrographs were printed  at x50,000  for spinal root samples 
and at x3fl,000 for sciatic nerve samples. As revealed by light microscopy, both 
grossly normal nerves and others with morphological abnormalities (i.e., naked 
axons) were included in the sample. 
Basal lamina measurements on each  cell included  the length  of plasma 
membrane observable, the total  length of the basal lamina corresponding  to 
the plasma membrane, and the number and size of  the gaps present in the basal 
lamina. Only those areas of the micropbaph in which plasma membrane was 
clearly observable, typically corresponding to regions of  the cell in which myelin 
lamellae were also clearly demarcated,  were included  in the measurements. 
After defining these parameters  on each myelinated fiber surface in the cross- 
section electron  micrographs, the actual  measurements  were obtained  with a 
Zeiss  IBAS image  analyzer  (Carl  Zeiss,  Oberkochen,  Federal  Republic  of 
Germany). The micrographs were placed directly on a digitizing tablet and the 
appropriate  contours were traced  with a magnetic  pen. The genotype of the 
Sehwann cells represented  in the electron  micrographs  was unknown to the 
individual measuring these parameters. 
Basal Lamina Control Measurements:  To assess the potential 
effects of both the particular  fixation protocol  adopted  for P1  immunocyto- 
chemistry, and the chimera  preparation  itself, one dyZJ/dy zJ and one shi/shi 
mouse as well as one 4-/+ ~  shi/shi chimera  were similarly prepared  and 
examined. From the chimera nerves, basal lamina measurements  were obtained 
from  104  +/+ and  105  shi/shi Schwann  cells identified  by their PI  MBP 
phenotype.  From the  dystrophic  mouse,  102  Sehwann  cells were similarly 
analyzed.  All  results  compared in  this  study  were  analyzed  for statistical 
significance by using the Mann-Whitney U test. 
RESULTS 
Light Microscopy 
Cross sections from the sciatic nerves and the midportion 
of all available ventral and dorsal roots were examined. The 
one chimera (A) with suspected behavioral deficiencies had 
small bundles of naked axons in both left and fight IA ventral 
roots. Although all other nerves were generally unremarkable, 
an  occasional  isolated axon  without  appropriate ensheath- 
ment  was  also  found  in  several  spinal  roots.  Thus,  the FIGURE  1  Demonstration of experimental approach and typical results. Serial semithin cross sections of a dystrophic ~-~ shiverer 
sciatic nerve are analyzed by light microscopy for structure using toluidine blue stain (A) and for Schwann cell genotype by P1 
MBP immunocytochemistry (B). Myelin-forming cells derived from the dystrophic cell line express P1  MBP and bind antibody 
detected  by  peroxidase-antiperoxidase immunocytochemistry.  Shiverer Schwann cells  do  not  express  P1  MBP and  remain 
unstained. Thin sections obtained from the immediately adjacent block face are viewed by electron microscopy; cells identified 
in both the immunocytochemical preparation (C also outlined in A and B) and in electron micrographs  (D) and photographed at 
high magnification (E) for subsequent analysis of basal lamina.  Partial profiles of the two dystrophic (indicated on myelin profiles 
with D) and the two shiverer (S) Schwann cells demonstrate intact basal laminas. Calibration bar (lower right of plate) represents: 
200/~m  (A and B); 12.0 p.rn (C); 5.4/~m  (D); and 1.0/~m (E). 
Schwann cell basal lamina phenotypes expressed by shiverer 
and dystrophic Schwann cells within both grossly normal and 
abnormal roots in  the same chimera were compared along 
with the basal lamina phenotype expressed by Schwann cells 
existing in the other chimeras whose nerves appeared normal 
at this level of analysis. 
Immunocytochemistry 
A total of 59 nerves (roots and sciatic) from three dy2S/dy2S 
.-~ shi/shi chimeras have been examined for the proportion 
and distribution of Pl-positive and negative Schwann cells. 
Although  the  proportion of each  type was  found to  vary 
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between the  same  nerves in  different chimeras,  all  nerves 
examined were mosaic. This circumstances permitted a com- 
parison of the basal lamina phenotypes expressed in nerves 
dominated by each genotype of Schwann cell. 
A  full description the  Schwann  cell mosaicism  and  the 
ensheathment properties of the nerves of these chimeras has 
been submitted for publication elsewhere. 
Basal Lamina Measurements 
The ultrastructural appearance of  the basal laminas realized 
by Schwann ceils in dystrophic and shiverer mice is presented 
in  Fig.  2.  Schwann cells  within the spinal roots (IAV and 
L4D) and sciatic nerve of the dystrophic mouse have typical 
discontinuities of  their basal laminas whereas the basal lamina 
in Schwann cells from shiverer mice is intact, demonstrating 
that the fixation protocol for optimal immunocytochemical 
detection of MBP P1  did not affect the visualization of the 
dystrophic abnormality. Within the dystrophic mouse,  the 
average basal  lamina coverage on Schwann  cells  in  spinal 
roots was  ~70%  (65-73%  depending upon the parameters 
averaged) whereas in sciatic nerve, the deficiency was  rela- 
tively less pronounced with 84%  of the plasma membranes 
covered (Table I). Within the mosaic nerves of the control +/ 
+  ~  shi/shi  chimera, both shi/shi  and  +/+ Schwann cells 
expressed ultrastructurally normal basal  laminas.  Although 
the occasional discontinuity in basal laminas was observed, 
particularly in spinal root samples, the average plasma mem- 
brane coverage was 98.6%  for both genotypes of Schwann 
cells.  Thus,  neither the  shiverer  mutant  nor the  chimera 
preparation itself appears to affect the normal realization of 
Schwann cell basal lamina. 
Among the  3  dyeJ/dy eJ ~  shi/shi  chimeras, no obvious 
differences in the ultrastructural appearance of basal lamina 
on  the  dy2J/dy e~  and  shi/shi  cells  were  apparent;  typical 
results from a sciatic nerve sample are included in Fig.  1 and 
from  a  spinal  root  sample  in  Fig.  3.  Both  genotypes  of 
Schwann  cell appeared to  express morphologically normal 
basal  lamina.  This  visual  impression  is  confirmed by the 
quantitative results (Table I).  No  significant differences in 
basal lamina measurements were found in all possible com- 
parisons of the total Schwann cell populations sampled  in 
each  of chimeras  A,  B,  and  C  and  the  control  chimera. 
However, all chimera results were significantly greater than 
the results obtained from the dystrophic mouse. 
To determine if any differences existed between the dys- 
trophic  and  shiverer  Schwann  cells  existing within  single 
chimera nerves, a statistical comparison between the results 
obtained for the two types of cells  in each nerve was per- 
formed. In  all  but  one  case,  these  dystrophic vs.  shiverer 
comparisons were not significant.  In the right IAV of chimera 
A, a significant difference was observed, but in this case the 
shiverer population expressed the lower mean basal lamina 
coverage. 
To ascertain if the basal lamina phenotype expressed by 
Schwann cells in roots containing naked axons differed from 
that expressed in morphologically  normal roots, the combined 
samples from the left and right L4V roots of chimera A were 
compared in  all possible  combinations with the  L4V root 
samples  of  chimera  B,  C,  and  control.  The  dystrophic 
Schwann cells in the L4V roots of chimera A did not differ 
from either the normal or shiverer cells in the L4V ventral 
roots of the control chimera. However, all other comparisons 
were significantly different. Despite the observations that the 
dystrophic Schwann cells in chimera A express a significantly 
improved basal lamina phenotype, this result could indicate 
that the extent of that amelioration may not be total in roots 
expressing other features of the dystrophic neuropathy. 
The right L4 dorsal  root of chimera A  had  the  highest 
proportion (89%) of genotypically dystrophic Schwann cells. 
Whereas the basal lamina measurements obtained from this 
FIGURE 2  (A) Typical Schwann cell abnormalities expressed in dystrophic mice.  Multiple gaps in  Schwann cell basal lamina 
(examples indicated by arrows) are observed on both myelinated and  unmyelinated fibers. (B) Schwann cells in shiverer  mice 
express intact basal  laminas. The MBP-deficient myelin in shiverer Schwann cells consistently  reveals multiple small interlamellar 
gaps (12). Bar, 0.4/~m. 
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5chwann  Cell Lamina Measurements 
Schwann cell source  Distance/cell in #m (X 4- SD)  Total distance/cell type in/zm 
Basal 
Geno-  Plasma  Basal lam-  Plasma  lamina  % 
Nerve  type  No.  membrane  ina gaps  % Coverage  membrane  gaps  Coverage 
C578L16 dy2J/dy  2j 
Sci(L)  Dy,  46  4.2 4- 1.7  0.7 ±  0.5  84.8 4- 8.5  191.1  30.0  84.4% 
L4V(L)  Dy.  26  6.2 4- 2.3  1.7 4- 1.9  74.8 ±  25.3  161.3  44.0  72.7% 
L4D(L)  Dy,  30  4.0 4- 1.4  1.4 ±  0.7  64.5 ±  14.3  121.3  42.0  65.4% 
XDy=  76.1 -4- 18.0  Y, dy =  473.7  116.0  75.5% 
4-14- *-~ shi/shi 
Sci(L)  +  40  5.2 ±  1.5  0.3 4- O.1  99.4 4- 1.0  209.4  1.4  99.3°/. 
Shi.  40  5.8 ±  1.7  0.3 +  0.1  99.5 ±  0.8  230.0  1.3  99.4*/. 
L4V(R)  +  31  4.9 _  1.5  0.1  ±  0.1  97.5 ±  2.2  153.1  3.8  97.5% 
Shi.  32  5.7 4- 1.4  0.1  ±  O.1  97.8 +  2.1  183.5  4.0  97.8*/. 
L4D(R)  +  33  4.2 4- 1.6  0.1  ±  0.7  98.7 ±  1.4  139.6  2.0  98.6*/o 
Shi.  33  4.0±  1.4  O.1  +0.1  98.34-2.0  130.4  2.2  98.3°/. 
+ = 98.6 ±  1.8  ~  + = 502.2  7.2  98.6*/, 
shi. = 98.6 ±  1.8  Y. shi. = 543.9  7.5  98.6*/, 
Chimera A dy2J/dy  2j *-~ shi/shi 
Sci(L)  Dy.  26  6.6 ±  2.2  0.2 +  0.3  96.9 ±  6.0  170.5  4.4  97.4% 
Shi.  25  7.2 _  3.1  0.2 ±  0.3  96.6 ±  6.1  179.3  4.9  97.3% 
L4V(L)  Dy.  51  5.8 __. 2.7  0.2 __. 0.2  95.9 --. 3.2  296.7  12.3  95.9% 
Shi,  48  5.5 ±  5.2  0.3 _  0.4  93.4 _  6.7  263.6  15.0  94.3% 
L4V(R)  Dy.  30  5.3 ±  1.2  0.1 __. 0.1  97.9 _  2.0  158.6  3.2  98.0% 
Shi.  32  4.8 _  1.4  0.3 +  0.3  93.8 ±  5.8  154.0  9.3  94.0% 
L4D(L)  Dy.  33  4.2 +  1.8  0.1 ±  0.2  97.0 --- 3.4  138.7  4.2  97.0% 
Shi,  30  4.7 _+ 1.7  0.1  _+ 0.1  97.2 +  2.3  139.5  3.6  97.4% 
L4D(R)  Dy.  33  4.8 4- 1.8  0.1 4- 0.1  97.6 _  3.2  159.7  3.5  97.8% 
Shi.  50  4.9 4- 1.4  0.1 _  0.2  97.8 4- 2.6  245.9  5.8  97.6% 
Dy. =  96.9 4- 3.6  Y.. Dy. =  924.2  27.6  97.0% 
Shi.  =  95.7 ±  5.3  Y. Shi.  =  982.3  38.6  96.1% 
Chimera B dy2J/dy  2J ~  shilshi 
Sci(L)  Dy.  22  7.9 +  4.0  0.0 +  0.0  100.0 +  0.0  173.6  0.0  100.0% 
Shi.  28  5.8 +  3.4  0.0 ±  0.0  100.0 ±  0.2  162.2  0.1  99.9% 
L4V(L)  Dy.  29  5.3 +  1.8  0.0 +  0.1  99.4 _+ 1.5  153.6  1.0  99.4% 
Shi.  35  5.4 4- 1.9  0.1  ±  0.5  99.6 ±  1.1  190.9  0.7  99.6% 
L4D(L)  Dy.  36  6.0 ±  1.7  0.0 4- 0.0  99.8 ±  0.5  216.4  0.4  99.8% 
Shi.  40  5.7 __. 1.9  0.0 4- 0.6  99.8 ±  0.8  227.2  0.7  99.7% 
Dy. =  99.7 -+ 0.9  Y, Dy. =  543.6  1.4  99.7% 
Shi.  =  99.9 4- 0.8  Y, Shi.  =  580.3  1.4  99.8% 
Chimera C dy2Jldy  2~ ~-* shilshi 
Sci(L)  Dy.  31  5.4 -  1.9  0.2 _+ 0.1  99.6 -+ 1.1  168.3  0.7  99.6% 
Shi.  31  5.4 -- 1.7  0.0 -- 0.1  99.6 -  1.2  168.7  0.6  99.6*/. 
L4V(L)  Dy.  34  6.5 4- 1.8  0.0 -- 0.1  99.6 +  1.0  219.8  1.0  99.5*/. 
Shi.  32  6.3 -- 1.8  0.1  4- 0.1  99.0 -  1.9  200.8  2.3  98.9% 
L4D(L)  Dy.  21  6.2 -  2.7  0.0 +  0.0  100.0 -- 0.0  131.1  0.0  100.0% 
Shi.  31  4.9 __ 2.4  0.1  __ 0.1  99.6 ±  1.2  151.6  0.5  99.7*/. 
X Dy. =  99.7 4- 0.9  ~  Dy. -- 519.2  1.7  99.7% 
Shi. -- 99.4 ±  1.5  ~  Shi.  =  521.1  3.4  99.3% 
Grand  Y~ Dy. =  1987.0  30.7  98.5% 
total  T. Shi.  =  2083.6  43.4  97.9% 
A+B+C 
Schwann cell lamina measurements obtained from Schwann cells in dystrophic (dy), normal (+) ~  shiverer (shi) chimera and dystrophic  ~  shiverer chimera 
nerves. Sci = sciatic nerve; L4 = fourth lumbar root; D = dorsal; V ~ ventral. Left and right sides are indicated  by (L) and (R) respectively. 
root were deficient relative to the dorsal roots of chimera B  shi/shi cells). Therefore, no convincing correlation between 
(26%  dystrophic  Schwann  cells) and  chimera  C  (9%  dys-  the proportion of dystrophic Schwann  cells existing within 
trophic Schwann  cells), they were similar to the values ob-  each nerve and relative basal lamina coverage is revealed by 
tained from  the control chimera (15%  +/+  cells and  85%  this analysis. 
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chimera C). Bar, 0.4 #m. 
DISCUSSION 
In the peripheral nerves of dystrophic ~-~ shiverer chimeras 
we have observed a striking amelioration of the basal lamina 
defect  typically  expressed by  Schwann  cells  in  dystrophic 
mice. As these dystrophic Schwann cells have undergone their 
entire primary development in a chimera preparation without 
further experimental manipulation, this result indicates that 
an influence extrinsic to dystrophic Schwann cells and ema- 
nating from unspecified shiverer cells is capable of conferring 
an apparently normal phenotype to the dystrophic Schwann 
cell. This result could therefore indicate that a primary genetic 
defect in some other cell type is entirely responsible for the 
abnormalities expressed by Schwann cells in dystrophic mice. 
However, if the genotype of the Schwann cell is not a relevant 
component of the pathogenesis, shiverer Schwann cells in this 
chimera preparation could also respond to such an abnormal 
extrinsic influence and express abnormal basal laminas. Al- 
though some shiverer Schwann cells in chimera A were par- 
tially deficient  in  basal  lamina  coverage,  they  nonetheless 
expressed  relatively  normal  basal  laminas  compared  with 
those of Schwann cells in dystrophic mice. Therefore, it is not 
yet possible to conclude that some extra Schwann cell com- 
ponent is capable of imposing the basal lamina deficiency on 
otherwise normal Schwann cells, and it remains possible that 
the Schwann cell genotype is relevant in the pathogenesis of 
the disease. Nonetheless, our results clearly demonstrate that 
the in  vivo phenotype of dystrophic Schwann  cells can be 
substantially ameliorated by an unknown influence emanat- 
ing from a population of nondystrophic cells simply coexisting 
in the same mouse. 
The results of two other experimental strategies have also 
revealed that the basal lamina phenotype expressed by dys- 
trophic Schwann cells can be modified. Bunge and co-workers 
(5,  6,  18,  19)  have demonstrated that  dystrophic Schwann 
cells,  but  not  genotypically normal  Schwann  cells,  express 
basal lamina deficiencies when grown in co-cultures of neu- 
rons and Schwann cells; the normal or dystrophic genotype 
of the  neurons  in  such  cultures  does  not  affect the  basal 
lamina phenotype.  However, the  addition  of genotypically 
normal fibroblasts to such cultures leads to a  marked amel- 
ioration of the defect expressed by dystrophic Schwann cells. 
These authors therefore proposed that the primary defect in 
dystrophic mice may be expressed by fibroblasts (20).  How- 
ever,  the  expression  of the  basal  lamina  abnormality  on 
dystrophic Schwann cells in culture can also be interpreted as 
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evidence for an intrinsic deficiency expressed by the Schwann 
cell itself; that is, mutant Schwann cells express their abnor- 
mality in  vitro,  but  that  phenotype can  be  normalized  by 
some influence emanating from genotypically normal fibro- 
blasts. A marked change in the phenotype expressed by dys- 
trophic Schwann cells is also observed in regenerated nerves 
within the dystrophic mouse. Not only do the axons in the 
spinal roots of  dystrophic mice become ensheathed after nerve 
crush (5,  6), but such regenerated fibers express intact basal 
laminas (6).  This result  requires that  changes in  either the 
local density of some cell type (e.g., fibroblasts) or the process 
of regeneration per se is adequate to modify this abnormality. 
In particular, these experiments demonstrate that the presence 
of genotypically normal cells  is  not  a  prerequisite  for dys- 
trophic Schwann cells to acquire a normal phenotype in vivo. 
In contrast, the results of the present study demonstrate that 
nerves undergoing their entire primary development and mat- 
uration  within  chimeras  and  without  further  experimental 
manipulations  can  also  provide  an  environment  in  which 
dystrophic Schwann cells achieve a normalized phenotype. 
The present chimera studies on dystrophic Schwann cells 
share one technical deficiency with the previous regeneration 
and  in  vitro  experiments;  in  each  case  the  dystrophic  or 
normal lamina phenotype has been established entirely on 
ultrastructural  criteria.  Thus,  we  are  not  able  to  deduce 
whether the normal appearance of basal lamina achieved by 
dystrophic Schwann  cells does,  in  fact, reflect basal lamina 
composed of all the normal components in their appropriate 
proportions and  whether such  basal laminas actually fulfill 
their normal function.  In general, the  multiple components 
of basal lamina are ubiquitous to the basal lamina of all cell 
types but little is known about their relative proportions and 
organization  in  different  tissues  (21).  The  majority  of the 
evidence suggests  that the  major basal lamina components 
are synthesized by the local cell (22,  23).  If this hypothesis is 
strictly  true,  then  the  influence  modifying the  dystrophic 
Schwann cell phenotype would have to act via some pathway 
stimulating the dystrophic Schwann cell itself.  Alternatively, 
the chimera results may indicate that one or more compo- 
nents synthesized by other cells may be incorporated into the 
basal laminas of dystrophic Schwann cells. Such cooperation 
between different cell types in the realization of fibronectin 
fibrils has been demonstrated in co-cultures of chick myogenic 
cells and rat fibroblasts. Differentially labeled, species-specific, 
antifibronectin  antibodies  label the  same fibrils,  indicating 
that fibronectin released into the medium by chick myogenic cells  can  be  incorporated  into  an  extracellular  matrix  laid 
down by fibroblasts  (24).  If such  a  sharing  of basal  lamina 
components were at the base of our present observations,  it 
would further indicate that dystrophic Schwann cells express 
appropriate receptors for basal lamina components and that 
their specific deficiency involves either a quantitative or qual- 
itative perturbation in one or more basal lamina components 
themselves.  In  the  latter  circumstances,  the  most  obvious 
source of such shared basal lamina components would be the 
shiverer  Schwann  cells  coexisting  within  the  same  nerves. 
However, the postulated role for fibroblasts in the ameliora- 
tion of the dystrophic Schwann cell phenotype in vitro could 
also be  operative  in  the in  vivo manipulations  that  lead  to 
normal-appearing  basal  laminas;  the  increased  numbers  of 
dystrophic fibroblasts in regenerating  nerves or the presence 
of functionally  normal fibroblasts derived from the shiverer 
cell line in the chimeras could provide a missing component 
directly to the Schwann cell or serve to provide some product 
necessary  for  the  appropriate  processing  of a  basal  lamina 
component. Despite these multiple possibilities,  the chimera 
results demonstrate that dystrophic Schwann cells in vivo can 
achieve a  morphologically normal phenotype:  Regardless of 
the  source  or  nature  of  that  normalizing  influence,  such 
dystrophic  Schwann  cells  are  able to  obtain  or express  the 
necessary component(s)  or function by existing in the envi- 
ronment provided within the nerves of dystrophic ~-> shiverer 
chimeras. 
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